Xiamen Amoytop Biotech Co Ltd (688278) — Financial Flexibility Index
Xiamen Amoytop Biotech Co Ltd (688278) has a Financial Flexibility Index of 0.84x as of September 2023. Free cash flow of CN¥375.30 Million (operating CF CN¥332.29 Million minus capex CN¥43.00 Million) represents 1% of total liabilities (CN¥447.44 Million). Check 688278 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xiamen Amoytop Biotech Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. See 688278 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Xiamen Amoytop Biotech Co Ltd. For the full company profile including market capitalisation, see market cap of Xiamen Amoytop Biotech Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥681.99 Million | CN¥430.63 Million | CN¥497.10 Million | ▼ -13.0% |
| 2023 | 1.58x | CN¥756.58 Million | CN¥512.10 Million | CN¥479.69 Million | ▼ -2.2% |
| 2022 | 1.61x | CN¥582.33 Million | CN¥363.16 Million | CN¥360.96 Million | ▼ -0.4% |
| 2021 | 1.62x | CN¥425.71 Million | CN¥234.78 Million | CN¥262.91 Million | ▲ +47.3% |
| 2020 | 1.10x | CN¥211.42 Million | CN¥92.61 Million | CN¥192.33 Million | ▲ +47.9% |
| 2019 | 0.74x | CN¥168.13 Million | CN¥123.30 Million | CN¥226.27 Million | ▲ +49.3% |
| 2018 | 0.50x | CN¥103.75 Million | CN¥89.15 Million | CN¥208.51 Million | ▲ +394.4% |
| 2017 | 0.10x | CN¥15.49 Million | CN¥-11.41 Million | CN¥153.86 Million | ▼ -87.2% |
| 2016 | 0.79x | CN¥129.46 Million | CN¥42.43 Million | CN¥164.49 Million | — |